Skip to main content

Our 2023 collections

Thyroid Cancer: A Global Threat

We are proud to announce a new thematic series, edited by Andy T. Y. Lau and Yasumasa Kato, entitled “Thyroid Cancer: A Global Threat”. In this collection, we welcome original articles focusing on areas including but not limited to molecular and genetic landscape, diagnostic tools and imaging techniques, advanced therapeutic modalities, epidemiology, and prevention strategies for thyroid cancer. 

Human Solute Carriers

We are proud to announce a new thematic series, edited by Andy T. Y. Lau and Yasumasa Kato, entitled "Human Solute Carriers (SLCs)." In this collection, we welcome original articles on a range of topics including but not limited to the role of SLCs in cancer cell survival, growth, and metastasis; SLCs as diagnostic biomarkers or therapeutic targets; and the development of novel strategies to modulate SLCs function in cancer therapy.

Ubiquitin Biology and Human Health

We are proud to present a new thematic series, edited by Andy T. Y. Lau and Amy Yan-Ming Xu, entitled “Ubiquitin Biology and Human Health”. We are honored to have the first kickoff article in this thematic series by Professor Aaron Ciechanover, Nobel Prize laureate in Chemistry of 2004. This collection will also comprise articles from other scientists of the field; the goal is to gather the latest knowledge and perspectives regarding ubiquitin research.


Announcing the launch of In Review

Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. Read more here.


Yasumasa Kato, Ohu University, Japan
Andy TY Lau, Shantou University Medical College, China

Celebrating 20 years

2021 marked the 20th year since Cancer Cell International published its very first articles. To mark the occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 20 years.

Trending articles

Click here to view which articles have been shared the most in the last month!

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2023 Speed
    34 days submission to first editorial decision for all manuscripts (Median)
    110 days submission to accept (Median)

    2023 Usage 
    1,052 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here